Geode Capital Management’s Immunome IMNM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Buy |
1,860,580
+117,523
| +7% | +$1.09M | ﹤0.01% | 2028 |
|
|
2025
Q1 | $11.7M | Buy |
1,743,057
+514,206
| +42% | +$3.46M | ﹤0.01% | 2196 |
|
|
2024
Q4 | $13.1M | Buy |
1,228,851
+21,396
| +2% | +$227K | ﹤0.01% | 2195 |
|
|
2024
Q3 | $17.7M | Buy |
1,207,455
+144,557
| +14% | +$2.11M | ﹤0.01% | 2043 |
|
|
2024
Q2 | $12.9M | Buy |
1,062,898
+630,419
| +146% | +$7.63M | ﹤0.01% | 2172 |
|
|
2024
Q1 | $10.7M | Buy |
432,479
+111,641
| +35% | +$2.76M | ﹤0.01% | 2284 |
|
|
2023
Q4 | $3.43M | Buy |
320,838
+236,130
| +279% | +$2.53M | ﹤0.01% | 2885 |
|
|
2023
Q3 | $708K | Buy |
84,708
+3,495
| +4% | +$29.2K | ﹤0.01% | 3467 |
|
|
2023
Q2 | $642K | Hold |
81,213
| – | – | ﹤0.01% | 3542 |
|
|
2023
Q1 | $405K | Hold |
81,213
| – | – | ﹤0.01% | 3727 |
|
|
2022
Q4 | $178K | Sell |
81,213
-193
| -0.2% | -$423 | ﹤0.01% | 4158 |
|
|
2022
Q3 | $361K | Hold |
81,406
| – | – | ﹤0.01% | 3902 |
|
|
2022
Q2 | $261K | Hold |
81,406
| – | – | ﹤0.01% | 4107 |
|
|
2022
Q1 | $462K | Buy |
81,406
+1,438
| +2% | +$8.16K | ﹤0.01% | 3971 |
|
|
2021
Q4 | $1.04M | Buy |
79,968
+25,299
| +46% | +$328K | ﹤0.01% | 3704 |
|
|
2021
Q3 | $1.33M | Buy |
54,669
+15,140
| +38% | +$369K | ﹤0.01% | 3535 |
|
|
2021
Q2 | $683K | Sell |
39,529
-9,802
| -20% | -$169K | ﹤0.01% | 3791 |
|
|
2021
Q1 | $1.67M | Buy |
49,331
+34,151
| +225% | +$1.16M | ﹤0.01% | 3341 |
|
|
2020
Q4 | $146K | Buy |
+15,180
| New | +$146K | ﹤0.01% | 3980 |
|